Isatuximab
From Infogalactic: the planetary knowledge core
| Monoclonal antibody | |
|---|---|
| Type | ? |
| Source | Chimeric (mouse/human) |
| Target | CD38 |
| Identifiers | |
| CAS Number | 1461640-62-9 |
| ATC code | none |
| Chemical data | |
| Formula | C6456H9932N1700O2026S44 |
| Molecular mass | 145.2 kg/mol |
Isatuximab is a monoclonal antibody (mAb) designed for the treatment of cancer.[1]
Previously known as SAR650984, it is an anti-CD38 mAb intended to treat relapsed or refractory multiple myeloma.[2]
This drug was developed by Sanofi-Aventis.
References
- ↑ Statement On A Nonproprietary Name Adopted By The USAN Council - Isatuximab, American Medical Association.
- ↑ ImmunoGen, Inc. Announces Data Presentations at Upcoming 57th ASH Annual Meeting and Exposition
<templatestyles src="Asbox/styles.css"></templatestyles>
 |
This monoclonal antibody-related article is a stub. You can help Wikipedia by expanding it. |
Categories:
- Chemical articles having calculated molecular weight overwritten
- Drugs that are a monoclonal antibody
- Articles without EBI source
- Chemicals that do not have a ChemSpider ID assigned
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Monoclonal antibody stubs
- Monoclonal antibodies
